Heart failure Flashcards

1
Q

Heart failure signs on X-ray

A
  1. Alveolar oedema (bat’s wings)
  2. kerley B lines (interstitial oedema)
  3. Cardiomegaly
  4. Dilated prominent upper lobe vessels
  5. Effusion (pleural)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

briefly:

Left Heart failure

common causes

symptoms

A

common causes are ischaemic heart disease, valvular heart disease, and hypertension.

Affects the blood flow systemically to the brain and the rest of the body.

Left ventricular failure: Symptoms:

  1. Dyspnoea, poor exercise tolerance
  2. Fatigue
  3. Orthopnoea
  4. Paroxysmal nocturnal dyspnoea (pnd),
  5. Nocturnal cough (±pink frothy sputum)
  6. Wheeze (cardiac ‘asthma’)
  7. Nocturia,
  8. Muscle wasting
  9. Weight loss
  10. Cold peripheries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RV Heart Failure briefly

common cuases

symptoms

A

common causes are chronic left heart failure resulting in back pressure to the right side of the heart, pulmonary hypertension, chronic lung disease, infarction to the right side of the heart and adult congenital heart disease. Affects blood flow to the lungs.

  1. Peripheral oedema
  2. Ascites
  3. Hepatomegaly
  4. Nausea
  5. Anorexia
  6. Pulsation in the neck, face
  7. epistaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is systolic heart failure?

A

Insufficient contraction of the heart i.e. reduced ejection fraction.

inability of the ventricle to contract normally, resulting ↓cardiac output. EF is <40%. Causes:IHD, MI, cardiomyopathy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is diastolic heart failure?

A

nsufficient relaxation of the heart muscles during diastole and hence decreased cardiac output. Patient has signs and symptoms of heart failure but ejection fraction is normal i.e. >45-50%. Common in elderly hypertensive patients

inability of the ventricle to relax and fill normally, causing ↑ filling pressures. ef is >50%. Causes: constrictive pericarditis, tamponade, restrictive cardiomyopathy, hypertension. NB: systolic and diastolic failure usually coexist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SIGNS OF LEFT HF

A
  1. Tachypnoea,
  2. orthopnoea
  3. paroxysmal nocturnal dyspnoea i.e. PND
  4. bibasal crepitations - PLEURAL EFFUSION
  5. PULMONARY OEDEMA
  6. laterally displaced apex beat - CARDIOMEGALY
  7. gallop rhythm,
  8. murmurs,
  9. cyanosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

RIGHT HEART FAILURE SIGNS

A
  1. Peripheral pitting oedema,
  2. hepatomegaly,
  3. increased JVP,
  4. parasternal heave,
  5. ascites.
  6. gallop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cellular mechnaisms of HF

A
  1. Myocyte hypertrophy
  2. Alterations in contractile properties of myocytes
  3. Progressive loss of myocytes through apoptosis, necrosis, atophagic death
  4. Beta-adrenergic desensitizaation
  5. Abnormal myocardial energetics and metabolism
  6. Reorganisation of structural collagen surroundings
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Neurohormonal adaptations in HF

A
  1. decreased CO in HF → “unloading” of high-pressure baroceptors in LV, carotid sinus, and aortic arch → afferent signals to the CNS →stimulate the release of ADH (AVP) from the posterior pituitary.
  2. ADH is a powerful vasoconstrictor, ↑ permeability of renal collecting ducts, →↑reabsorption of water. These afferent signals to the CNS also activate efferent SNS pathways that innervate the heart, kidney, peripheral vasculature, and skeletal muscles.
  3. SNS stimulation of kidneyrelease of renin → ↑ angiotensin II and aldosterone.
  4. The activation of RAA system → salt and water retention & vasoconstriction of the peripheral vasculature, myocyte hypertrophy, myocyte cell death, and myocardial fibrosis.
  5. While these neurohormonal mechanisms facilitate short-term adaptation by maintaining blood pressure, and hence perfusion to vital organs, these same neurohormonal mechanisms are believed to contribute to end-organ changes in the heart and the circulation, and to the excessive salt and water retention in advanced HF.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Farmingham criteria

A

Major criteria

  1. Paroxysmal nocturnal dyspnea or orthopnea
  2. Neck vein distention
  3. Rales
  4. Cardomegaly
  5. Acute pulmonary edema
  6. S3 gallop
  7. Increased jugular venous pressure >16 cm H2O
  8. Circulation time >25 s
  9. Hepatojugulr reflux

Minor criteria

  1. Ankle edema
  2. Night cough
  3. Dyspnea on exertion
  4. Hepatomegaly
  5. Pleural effusion
  6. Vital capacity decresed 1/3 from maximum
  7. Tachycardia (heart rate >120 beats/min)

Major or minor criterion
Weight loss >4.5 kg in 5 days in response to treatment

Definite congestive heart failure = 2 major criteria
or 1 major and 2 minor criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cor pulmonale aetiology

A

_Diseases Leading to Hypoxic Vasoconstriction _

  1. Chronic bronchitis
  2. Chronic obstructive pulmonary disease
  3. Cystic fibrosis
  4. Chronic hypoventilation
  5. Obesity
  6. Neuromuscular disease
  7. Chest wall dysfunction
  8. Living at high altitudes

_Diseases That Cause Occlusion of the Pulmonary Vascular Bed _

  1. Recurrent pulmonary thromboembolism
  2. Primary pulmonary hypertension
  3. Venocclusive disease
  4. Collagen vascular disease
  5. Drug induced lung disease

_Diseases That Lead to Parenchymal Disease _

  1. Chronic bronchitis
  2. Chronic obstructive pulmonary disease
  3. Bronchiectasis
  4. Cystic fibrosis
  5. Pneumoconiosis
  6. Sarcoid
  7. Idiopathic pulmonary fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

COPD and cor pulmonale. Mechanism leading to pulmonary HTN

A

80% to 90% of cases of cor pulmonale are caused by COPD.

Mechanisms leading to pulmonary hypertension include:    
  1. Pulmonary vasoconstriction resulting from any condition causing alveolar hypoxia or acidosis
    1. Anatomic reduction of the pulmonary vascular bed (e.g., emphysema, interstitial lung disease, pulmonary emboli)
    2. ** Increased blood viscosity** (e.g., polycythemia vera, Waldenström’s macroglobulinemia)
    3. Increased pulmonary blood flow (e.g., left-to-right shunts)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Systolic dysfunction HF

A

Heart failure caused by systolic dysfunction is defined as a ↓ EF (< 50%) and ↑ LV end-diastolic volumes.

It is caused by inadequate left ventricular contractility or ↑ afterload.

The heart compensates for low EF and ↑ preload through hypertrophy and ventricular dilation (Frank-Starling law), but the compensation ultimately fails, leading to ↑ myocardial work and worsening systolic function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diastolic dysfunction HF

A

Defined by ↓ ventricular compliance with normal systolic function.

The ventricle has either impaired active relaxation (2° to ischemia, aging, and/or hypertrophy) or impaired passive filling (scarring from prior MI; restrictive cardiomyopathy).

LV end-diastolic pressure ↑, cardiac output
remains essentially normal, and EF is normal or ↑.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of acute HF

A

Acute:
■ Correct underlying causes such as arrhythmias, myocardial ischemia, and drugs (e.g., CCBs, antiarrhythmics, NSAIDs, alcohol, thyroid and valvular disease, high-output states).
■ Diurese aggressively with loop and thiazide diuretics

Give ACEIs to all patients who can tolerate them. If a patient cannot tolerate ACEIs, consider an angiotensin receptor blocker (ARB).

β-blockers should not be used during decompensated CHF but should be started once the patient is euvolemic.

■ Treat acute pulmonary congestion with LMNOP:

  1. Furosemide
  2. Morphine
  3. Nitrates
  4. Oxygen
  5. Position
17
Q

Causes of Cardiac Failure

A

_ Main causes_

  1. ** Ischaemic heart disease (35-40%)**
  2. ** Cardiomyopathy (dilated) (30-34%)**
  3. ** Hypertension (15-20%)**

_ Other causes_

  1. ** Cardiomyopathy** (undilated): hypertrophic, restrictive (amyloidosis, sarcoidosis)
  2. Valvular heart disease (mitral, aortic, tricuspid)
  3. ** Congenital heart disease** (ASD, VSD)
  4. Alcohol and drugs (chemotherapy - trastuzumab, imatinib)
  5. ** Hyperdynamic circulation** (anaemia, thyrotoxicosis, haemochromatosis, Paget’s disease)
  6. Right heart failure (RV infarct, pulmonary hypertension, pulmonary embolism, (COPD))
  7. Tricuspid incompetence
  8. Arrhythmias (atrial fibrillation, bradycardia (complete heart block, the sick sinus syndrome))
  9. Pericardial disease (constrictive pericarditis, pericardial effusion)
  10. Infections (Chagas’ disease), e.g. myocarditis
18
Q
A
19
Q

Epidemiology of heart failure

A

Epidemiology: >10% of >65 y/o,

2% overall population

20
Q

Management of chronic cardiac failure

A

Stop smoking. Eat less salt. Optimize weight & nutrition.

  • Treat the cause (eg if dysrhythmias; valve disease).
  • Treat exacerbating factors (anaemia, thyroid disease, infection, ↑BP).
  • Avoid exacerbating factors, eg nsaids (fluid retention) and verapamil (–ve inotrope).

• Drugs:

  1. ACEI: Consider in all those with LV systolic dysfunction; improves symptoms and prolongs life
  2. Diuretics for symptomatic relief, also reduce risk of death. Loop, potassium sparing.
  3. β-blockers (eg carvedilol) decrease mortality in heart failure. Initiate after diuretic and ACEI.
  4. Spironolactone: Spironolactone (25mg/24h po) ↓mortality by 30% when added to conventional therapy.Use in those still symptomatic despite optimal therapy as listed above. It improves endothelial dysfunction (↑nitric oxide bioavailability) and **prevents remodelling **
  5. Digoxin helps symptoms even in those with sinus rhythm;Should be considered for patients with lv systolic dysfunction who have signs or symptoms of heart failure while receiving standard therapy
  6. Vasodilators: The combination of hydralazine (SE: drug-induced lupus) and isosorbide dinitrate should be used if intolerant of ACEI and ARBs as it reduces mortality
21
Q

causes of intractable heart failure and what to do next??

A

Intractable heart failure:

Reassess the cause. Are they taking the drugs?—at maximum dose? Switching furosemide to bumetanide (one 5mg tab≈200mg furosemide) might help: absorption may be better. Consider admitting for:

  • Strict bed rest ± Na+ & fluid restriction (≲1.5L/24h po).
  • Metolazone (as above) and iv furosemide
  • Opiates and iv nitrates may relieve symptoms

• Weigh daily.

Do frequent u&e (beware K+↓).

  • DVT prophylaxis: heparin + ted stockings
  • Cardiac resynchronisation therapy: biventricular pacing improves outcomes in EF<35%
22
Q

Describe dilated cardiomyopathy

Typical ECG features

Common complication?

A

Is a syndrome of global ventricular dysfunction and dilatation.

Aetiology often unconfirmed, more common in males.

Often LBBB and poor R wave progression on ECG.

Anticoagulation may be necessary: incidence of AF and ventricular thrombus is high

23
Q

Causes of dilated cardiomyopathy

A
  1. Alcohol
  2. Undiagnosed HTN
  3. Autoimmune disease
  4. Nutritional deficiency: thiamine
  5. Muscular dystrophies
  6. Peripartum
  7. Drugs (doxorubicin)
  8. Infiltration (haemochromatosis, sarcoidosis)
  9. Tachycardia
24
Q

Restictive cardiomopathy

Describe

Complication?

Causes

A

Produces symptoms identical to constrictive pericarditis.
The ventricles are excessively rigid and impede diastolic filling.

AF may occur

CAUSES:

  1. Idiopathic
  2. Connective tissue disease
  3. Amyloid
  4. Sarcoid
  5. Metabolic and storage disease
  6. Carcinoid
  7. Malignancy or radiotherapy
25
Q
A